179 related articles for article (PubMed ID: 8695681)
21. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
[TBL] [Abstract][Full Text] [Related]
22. Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.
Baltimore RS; Radnay-Baltimore K; von Graevenitz A; Dolan TF
Helv Paediatr Acta; 1982; 37(6):547-54. PubMed ID: 6820015
[TBL] [Abstract][Full Text] [Related]
23. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
[TBL] [Abstract][Full Text] [Related]
24. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
[TBL] [Abstract][Full Text] [Related]
25. Selective media for the quantitation of bacteria in cystic fibrosis sputum.
Wong K; Roberts MC; Owens L; Fife M; Smith AL
J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825
[TBL] [Abstract][Full Text] [Related]
26. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis.
Taylor L; Corey M; Matlow A; Sweezey NB; Ratjen F
Pediatr Pulmonol; 2006 Sep; 41(9):839-43. PubMed ID: 16850448
[TBL] [Abstract][Full Text] [Related]
27. [Distribution and drug resistance of the isolated bacteria from children with acute respiratory infection].
Guo J; Cui ZZ; Huang Y; Yu AM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):579-82. PubMed ID: 18947473
[TBL] [Abstract][Full Text] [Related]
28. Pseudomonas aeruginosa and Burkholderia cepacia cannot be detected by PCR in the breath condensate of patients with cystic fibrosis.
Vogelberg C; Hirsch T; Rösen-Wolff A; Kerkmann ML; Leupold W
Pediatr Pulmonol; 2003 Oct; 36(4):348-52. PubMed ID: 12950050
[TBL] [Abstract][Full Text] [Related]
29. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
Cahen P; Le Bourgeois M; Delacourt C; Coustère C; Nicaise P; de Blic J; Véron M; Scheinmann P; Gaillard JL
Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary infection in mild variant cystic fibrosis: implications for care.
Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
[TBL] [Abstract][Full Text] [Related]
31. RISA-HPLC analysis of lung bacterial colonizers of cystic fibrosis children.
Nazaret S; Assade F; Brothier E; Freydière AM; Bellon G; Cournoyer B
J Microbiol Methods; 2009 Jan; 76(1):58-69. PubMed ID: 18929602
[TBL] [Abstract][Full Text] [Related]
32. Mucoid Escherichia coli in cystic fibrosis.
Macone AB; Pier GB; Pennington JE; Matthews WJ; Goldmann DA
N Engl J Med; 1981 Jun; 304(24):1445-9. PubMed ID: 6785645
[TBL] [Abstract][Full Text] [Related]
33. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
34. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
35. Transtracheal aspiration in pulmonary infection in children with cystic fibrosis.
Brook I; Fink R
Eur J Respir Dis; 1983 Jan; 64(1):51-7. PubMed ID: 6825749
[TBL] [Abstract][Full Text] [Related]
36. [Microbiological parameters of clinical interest in pulmonary infection in cystic fibrosis].
Ballestero S; Escobar H; Suárez L; Baquero F
Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):245-9. PubMed ID: 9044640
[TBL] [Abstract][Full Text] [Related]
37. [Bacteriological and mycological analysis of material taken from lower respiratory tract in patients with malignancy].
Szymankiewicz M; Kowalewski J; Dancewicz M
Pol Merkur Lekarski; 2006 Sep; 21(123):218-22. PubMed ID: 17163180
[TBL] [Abstract][Full Text] [Related]
38. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis.
da Silva Filho LV; Tateno AF; Martins KM; Azzuz Chernishev AC; Garcia Dde O; Haug M; Meisner C; Rodrigues JC; Döring G
Pediatr Pulmonol; 2007 Oct; 42(10):938-44. PubMed ID: 17722007
[TBL] [Abstract][Full Text] [Related]
39. Quantitative effect of roxithromycin and rifampicin on mucoid cultures from directly plated sputum of cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa.
Dupont MJ; Lapointe JR
Drugs Exp Clin Res; 1990; 16(12):597-605. PubMed ID: 2130001
[TBL] [Abstract][Full Text] [Related]
40. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.
Bauernfeind A; Bertele RM; Harms K; Hörl G; Jungwirth R; Petermüller C; Przyklenk B; Weisslein-Pfister C
Infection; 1987; 15(4):270-7. PubMed ID: 3117700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
